Omoniyi J Adedokun Selected Research

Serum Albumin

1/2020	Population Pharmacokinetics and Exposure-Response Modeling of Golimumab in Adults With Moderately to Severely Active Ulcerative Colitis.
1/2020	Population Pharmacokinetics and Exposure-Response Modeling Analyses of Ustekinumab in Adults With Moderately to Severely Active Ulcerative Colitis.
1/2019	Population Pharmacokinetics and Exposure-Response Modeling Analyses of Golimumab in Children With Moderately to Severely Active Ulcerative Colitis.
1/2017	Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies.
12/2009	Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Omoniyi J Adedokun Research Topics

Disease

15	Ulcerative Colitis 12/2020 - 12/2009
12	Crohn Disease (Crohn's Disease) 01/2022 - 07/2011
9	Body Weight (Weight, Body) 11/2021 - 12/2009
7	Infections 01/2022 - 01/2014
3	Rheumatoid Arthritis 01/2022 - 12/2009
3	Pediatric ulcerative colitis 01/2019 - 12/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 09/2015
2	Psoriatic Arthritis 01/2022 - 01/2019
2	Skin Neoplasms (Skin Cancer) 12/2020 - 01/2019
2	Neoplasms (Cancer) 12/2020 - 01/2019
2	Disease Progression 11/2015 - 09/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2020
1	Heart Arrest (Cardiac Arrest) 12/2020
1	Inflammation (Inflammations) 01/2020
1	Hemorrhage 01/2019
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Ankylosing Spondylitis 01/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	Ulcer 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2018
1	Dementia (Dementias) 09/2015
1	Sepsis (Septicemia) 01/2014
1	Tuberculosis (Tuberculoses) 01/2014
1	Heart Failure 01/2014

Drug/Important Bio-Agent (IBA)

11	Ustekinumab (CNTO 1275)FDA Link 01/2022 - 11/2016
11	golimumab FDA Link 01/2022 - 01/2014
11	Monoclonal AntibodiesIBA 01/2022 - 07/2011
5	Interleukin-23 (Interleukin 23)IBA 01/2022 - 11/2016
5	Interleukin-12 (IL 12)IBA 01/2020 - 11/2016
5	Serum AlbuminIBA 01/2020 - 12/2009
5	Infliximab (Remicade)FDA Link 01/2019 - 12/2009
4	AntibodiesIBA 01/2020 - 12/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 12/2009
3	bapineuzumabIBA 01/2016 - 09/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Alkaline PhosphataseIBA 01/2020 - 01/2017
2	Biological ProductsIBA 01/2020 - 01/2019
2	C-Reactive ProteinIBA 01/2020 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 01/2020 - 12/2009
2	Pharmaceutical PreparationsIBA 01/2019 - 12/2014
2	Apolipoproteins E (ApoE)IBA 11/2015 - 09/2015
1	guselkumabIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	LactoferrinIBA 01/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2020
1	Azathioprine (Imuran)FDA LinkGeneric 01/2019
1	InterleukinsIBA 10/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	Sodium Glutamate (Accent)IBA 07/2011

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2014
2	Investigational Therapies (Experimental Therapy) 01/2017 - 01/2014
1	Biological Therapy 01/2022
1	Immunotherapy 01/2016